Willem Overwijk, University of Texas MD Anderson Cancer Center (IMAGE)
Caption
Willem Overwijk and colleagues identified a common vaccine component that sets off an immune response at the injection site that detracts from T cell attack on tumors.
Credit
University of Texas MD Anderson Cancer Center
Usage Restrictions
None
License
Licensed content